Acrivastine - CISMeF

Preferred Label : Acrivastine;

NCIt synonyms : (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic Acid; 2-Propenoic Acid, 3-(6-(1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-,(E,E)-;

NCIt definition : A synthetic alkylamine with non-sedative antihistaminergic activity. Acrivastine competitively blocks the histamine H1 receptor and limits the typical allergic and anaphylactic responses, including bronchoconstriction, vasodilation, increased capillary permeability, and spasmodic contraction of gastrointestinal smooth muscle, caused by actions of histamine on bronchial, and gastrointestinal smooth muscles, and on capillaries. This drug also prevents histamine-induced pain and itching of the skin and mucous membranes. (NCI05);

UNII : A20F9XAI7W;

InChIKey : PWACSDKDOHSSQD-IUTFFREVSA-N;

CAS number : 87848-99-5;

Drug name : Semprex;

Molecule name : BW 825C;

Chemical formula : C22H24N2O2;

Details

Origin ID

C47383;

UMLS CUI

C0054340;

Currated CISMeF NLP mapping
- Acrivastine [ICD-11 Extension code]
- Acrivastine (substance) [SNOMED CT concept]
- Product containing acrivastine (medicinal product) [SNOMED CT concept]
- acrivastine [MeSH concept]
- acrivastine [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Acrivastine [ICD-11 Extension code]
- Acrivastine (substance) [SNOMED CT concept]
- Product containing acrivastine (medicinal product) [SNOMED CT concept]
- acrivastine [ATC Code]
- acrivastine [MeSH concept]
- acrivastine [MeSH Supplementary Concept]
Validated automatic mappings to BTNT
- acrivastine [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients